Medicines Co. Sue Teva Again Over Angiomax

Angiomax Drug maker Medicines Co. have announced that they have filed lawsuits in the U.S. District Court for the District of Delaware against Teva Pharmaceutical Laboratories Inc. and Pliva Hrvatsk following their submissions to the U.S. Food and Drug Administration to approve a generic version of the company’s anti-clotting agent Angiomax.

This entry was posted on Wednesday, January 6th, 2010 at 8:26 am and is filed under Intellectual Property, Patents, Teva, drugs, infringement, pharmaceuticals, pharmaceuticals and Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply